ADA在恶性\结核性及肝硬化腹腔积液患者中的表达(1)
 |
| 第1页 |
参见附件(1400KB，2页)。
[摘要] 目的:探讨ADA在肿瘤、结核性腹腔积液及肝硬化腹腔积液患者中的表达和意义。方法:选择15例结核性腹腔积液患者、30例恶性腹腔积液患者和30例肝硬化腹腔积液患者,采用ELISA法测定腹腔积液中血清ADA活性。结果:结核性腹腔积液患者ADA水平高于恶性腹腔积液患者和肝硬化腹腔积液患者(P<0.05)。结核性腹腔积液中,腹腔积液ADA/血清ADA>1.2者显著多于其他组(P<0.05)。结论:腹腔积液ADA/血清ADA比值较单独测定腹腔积液ADA水平在鉴别良、恶性腹腔积液中更有意义。
[关键词] 结核性腹腔积液;恶性腹腔积液;肝硬化腹腔积液;腺苷脱氨酶
[中图分类号] R442.5[文献标识码]A [文章编号]1673-7210(2010)04(b)- 018-02
Expression of ADA in patients with m alignant, tuberculous and liver cirrhosis ascites
LI Xi, SHI Binglong
(Department of Gastroenterology, Peking University Shenzhen Hospital, Shenzhen 518036, China)
[Abstract] Objective: To investigate the expression and significance of ADA in patients with m alignant, tuberculous and liver cirrhosis ascites. Methods: 15 cases of patients with tuberculous ascites, 30 cases of patients with m alignant ascites and 30 cases of patients with liver cirrhosis ascites were selected, and the serum ADA activity of ascites was determined by using ELISA ......
您现在查看是摘要介绍页，详见PDF附件(1400KB，2页)。